ESMC — Escalon Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapContrarian

Annual income statement for Escalon Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10.7	12.2	12	12	12.7
Cost of Revenue
Gross Profit	4.61	5.48	5.15	5.51	5.57
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	11.2	11.7	12.1	11.9	12.7
Operating Profit	-0.47	0.479	-0.104	0.133	0.045
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.018	0.457	-0.125	0.106	2.87
Provision for Income Taxes
Net Income After Taxes	0.018	0.457	-0.125	0.106	4.01
Net Income Before Extraordinary Items
Net Income	0.018	0.457	-0.125	0.106	4.01
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.034	0.222	-0.177	0.028	2.01
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.005	0.03	-0.024	0.002	0.013